Your browser doesn't support javascript.
loading
Report from the HarmoSter study: different LC-MS/MS androstenedione, DHEAS and testosterone methods compare well; however, unifying calibration is a double-edged sword.
Fanelli, Flaminia; Peitzsch, Mirko; Bruce, Stephen; Cantù, Marco; Temchenko, Anastasia; Mezzullo, Marco; Lindner, Johanna M; Hawley, James M; Ackermans, Mariette T; Van den Ouweland, Jody; Koeppl, Daniel; Nardi, Elena; MacKenzie, Finlay; Binz, Pierre-Alain; Rauh, Manfred; Keevil, Brian G; Vogeser, Michael; Eisenhofer, Graeme; Heijboer, Annemieke C; Pagotto, Uberto.
Afiliación
  • Fanelli F; Department of Medical and Surgical Sciences, Endocrinology Research Group, Center for Applied Biomedical Research, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Peitzsch M; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Bruce S; Clinical Chemistry Laboratory, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Cantù M; Laboratory of Clinical Biochemistry and Pharmacology, Institute of Laboratory Medicine EOLAB, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Temchenko A; Department of Medical and Surgical Sciences, Endocrinology Research Group, Center for Applied Biomedical Research, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Mezzullo M; Department of Medical and Surgical Sciences, Endocrinology Research Group, Center for Applied Biomedical Research, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Lindner JM; Institute of Laboratory Medicine, Hospital of the University of Munich (LMU), Munich, Germany.
  • Hawley JM; Department of Clinical Biochemistry, University Hospital South Manchester, Manchester NHS Foundation Trust, Manchester, UK.
  • Ackermans MT; Faculty of Science, Van't Hoff Institute for Molecular Sciences, University of Amsterdam, Amsterdam, Netherlands.
  • Van den Ouweland J; Department of Clinical Chemistry, Canisius-Wilhelmina Hospital, Nijmegen, Netherlands.
  • Koeppl D; Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany.
  • Nardi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • MacKenzie F; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Binz PA; Clinical Chemistry Laboratory, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
  • Rauh M; Department of Pediatrics and Adolescent Medicine, University Hospital, Erlangen, Germany.
  • Keevil BG; Department of Clinical Biochemistry, University Hospital South Manchester, Manchester NHS Foundation Trust, Manchester, UK.
  • Vogeser M; Institute of Laboratory Medicine, Hospital of the University of Munich (LMU), Munich, Germany.
  • Eisenhofer G; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Heijboer AC; Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam UMC, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Pagotto U; Department of Medical and Surgical Sciences, Endocrinology Research Group, Center for Applied Biomedical Research, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Clin Chem Lab Med ; 62(6): 1080-1091, 2024 May 27.
Article en En | MEDLINE | ID: mdl-38205643
ABSTRACT

OBJECTIVES:

Current liquid chromatography-tandem mass spectrometry (LC-MS/MS) applications for circulating androgen measurements are technically diverse. Previously, variable results have been reported for testosterone. Data are scarce for androstenedione and absent for dehydroepiandrosterone sulfate (DHEAS). We assessed the agreement of androstenedione, DHEAS and testosterone LC-MS/MS measurements among nine European centers and explored benefits of calibration system unification.

METHODS:

Androgens were measured twice by laboratory-specific procedures in 78 patient samples and in EQA materials. Results were obtained by in-house and external calibration. Intra- and inter-laboratory performances were valued.

RESULTS:

Intra-laboratory CVs ranged between 4.2-13.2 % for androstenedione, 1.6-10.8 % for DHEAS, and 4.3-8.7 % and 2.6-7.1 % for female and male testosterone, respectively. Bias and trueness in EQA materials were within ±20 %. Median inter-laboratory CV with in-house vs. external calibration were 12.0 vs. 9.6 % for androstenedione (p<0.001), 7.2 vs. 4.9 % for DHEAS (p<0.001), 6.4 vs. 7.6 % for female testosterone (p<0.001) and 6.8 and 7.4 % for male testosterone (p=0.111). Median bias vs. all laboratory median with in-house and external calibration were -13.3 to 20.5 % and -4.9 to 18.7 % for androstenedione, -10.9 to 4.8 % and -3.4 to 3.5 % for DHEAS, -2.7 to 6.5 % and -11.3 to 6.6 % for testosterone in females, and -7.0 to 8.5 % and -7.5 to 11.8 % for testosterone in males, respectively.

CONCLUSIONS:

Methods showed high intra-laboratory precision but variable bias and trueness. Inter-laboratory agreement was remarkably good. Calibration system unification improved agreement in androstenedione and DHEAS, but not in testosterone measurements. Multiple components, such as commutability of calibrators and EQA materials and internal standard choices, likely contribute to inter-laboratory variability.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Testosterona / Sulfato de Deshidroepiandrosterona / Androstenodiona Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Testosterona / Sulfato de Deshidroepiandrosterona / Androstenodiona Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article